US Stock MarketDetailed Quotes

XBIO Xenetic Biosciences

Watchlist
  • 4.0126
  • +0.0226+0.57%
Close Nov 21 16:00 ET
6.19MMarket Cap-1508P/E (TTM)

Xenetic Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
51.66%-459.04K
58.62%-525.1K
-5.16%-1.16M
11.46%-4.11M
-5.61%-793.03K
12.01%-949.63K
-74.11%-1.27M
47.19%-1.1M
1.93%-4.65M
48.52%-750.91K
Net income from continuing operations
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
-16.07%-6.55M
19.50%-1.48M
Depreciation and amortization
----
----
----
--0
----
----
----
----
-23.78%27.04K
--0
Other non cash items
----
----
----
----
----
----
----
----
--1.79M
--488.75K
Change In working capital
-239.96%-49.9K
345.79%706.77K
86.88%-41.31K
38.43%-262.73K
144.63%303.9K
108.48%35.66K
-158.35%-287.55K
49.49%-314.74K
-192.52%-426.69K
-52.33%124.23K
-Change in prepaid assets
427.06%528.29K
62.86%-164.34K
116.16%51.79K
53.99%-47.73K
469.94%876.73K
-232.75%-161.53K
-261.48%-442.5K
-22.10%-320.45K
-136.27%-103.74K
-168.00%-236.99K
-Change in payables and accrued expense
-393.23%-578.2K
5,726.81%871.11K
57.06%-93.09K
24.25%-263.57K
-1,261.14%-258.91K
186.36%197.18K
-93.08%14.95K
39.42%-216.79K
-176.12%-347.95K
-92.56%22.3K
-Change in other current assets
--0
--0
--0
94.32%48.58K
-192.62%-313.92K
--0
4,776.35%140K
7,849.91%222.5K
108.87%25K
187.46%338.92K
Cash from discontinued investing activities
Operating cash flow
51.66%-459.04K
58.62%-525.1K
-5.16%-1.16M
11.46%-4.11M
-5.61%-793.03K
12.01%-949.63K
-74.11%-1.27M
47.19%-1.1M
1.93%-4.65M
48.52%-750.91K
Investing cash flow
Cash flow from continuing investing activities
0
-500K
0
Net intangibles purchase and sale
----
----
----
--0
----
----
----
----
---500K
--0
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
----
----
----
----
---500K
--0
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position
-31.95%7.3M
-34.77%7.82M
-31.41%8.98M
-28.21%13.1M
-29.41%9.78M
-28.15%10.73M
-25.76%11.99M
-28.21%13.1M
58.26%18.24M
-29.71%13.85M
Current changes in cash
51.66%-459.04K
58.62%-525.1K
-5.16%-1.16M
20.06%-4.11M
-5.61%-793.03K
12.01%-949.63K
-3.27%-1.27M
47.19%-1.1M
-176.63%-5.15M
48.52%-750.91K
End cash Position
-30.04%6.84M
-31.95%7.3M
-34.77%7.82M
-31.41%8.98M
-31.41%8.98M
-29.41%9.78M
-28.15%10.73M
-25.76%11.99M
-28.21%13.1M
-28.21%13.1M
Free cash flow
51.66%-459.04K
58.62%-525.1K
-5.16%-1.16M
20.06%-4.11M
-5.61%-793.03K
12.01%-949.63K
-3.27%-1.27M
47.19%-1.1M
-8.63%-5.15M
48.52%-750.91K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 51.66%-459.04K58.62%-525.1K-5.16%-1.16M11.46%-4.11M-5.61%-793.03K12.01%-949.63K-74.11%-1.27M47.19%-1.1M1.93%-4.65M48.52%-750.91K
Net income from continuing operations 58.63%-436.67K-21.22%-1.27M-39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K-16.07%-6.55M19.50%-1.48M
Depreciation and amortization --------------0-----------------23.78%27.04K--0
Other non cash items ----------------------------------1.79M--488.75K
Change In working capital -239.96%-49.9K345.79%706.77K86.88%-41.31K38.43%-262.73K144.63%303.9K108.48%35.66K-158.35%-287.55K49.49%-314.74K-192.52%-426.69K-52.33%124.23K
-Change in prepaid assets 427.06%528.29K62.86%-164.34K116.16%51.79K53.99%-47.73K469.94%876.73K-232.75%-161.53K-261.48%-442.5K-22.10%-320.45K-136.27%-103.74K-168.00%-236.99K
-Change in payables and accrued expense -393.23%-578.2K5,726.81%871.11K57.06%-93.09K24.25%-263.57K-1,261.14%-258.91K186.36%197.18K-93.08%14.95K39.42%-216.79K-176.12%-347.95K-92.56%22.3K
-Change in other current assets --0--0--094.32%48.58K-192.62%-313.92K--04,776.35%140K7,849.91%222.5K108.87%25K187.46%338.92K
Cash from discontinued investing activities
Operating cash flow 51.66%-459.04K58.62%-525.1K-5.16%-1.16M11.46%-4.11M-5.61%-793.03K12.01%-949.63K-74.11%-1.27M47.19%-1.1M1.93%-4.65M48.52%-750.91K
Investing cash flow
Cash flow from continuing investing activities 0-500K0
Net intangibles purchase and sale --------------0-------------------500K--0
Cash from discontinued investing activities
Investing cash flow --------------0-------------------500K--0
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position -31.95%7.3M-34.77%7.82M-31.41%8.98M-28.21%13.1M-29.41%9.78M-28.15%10.73M-25.76%11.99M-28.21%13.1M58.26%18.24M-29.71%13.85M
Current changes in cash 51.66%-459.04K58.62%-525.1K-5.16%-1.16M20.06%-4.11M-5.61%-793.03K12.01%-949.63K-3.27%-1.27M47.19%-1.1M-176.63%-5.15M48.52%-750.91K
End cash Position -30.04%6.84M-31.95%7.3M-34.77%7.82M-31.41%8.98M-31.41%8.98M-29.41%9.78M-28.15%10.73M-25.76%11.99M-28.21%13.1M-28.21%13.1M
Free cash flow 51.66%-459.04K58.62%-525.1K-5.16%-1.16M20.06%-4.11M-5.61%-793.03K12.01%-949.63K-3.27%-1.27M47.19%-1.1M-8.63%-5.15M48.52%-750.91K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data